Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.13
+0.84 (9.04%)
At close: Mar 9, 2026, 4:00 PM EDT
10.17
+0.04 (0.38%)
After-hours: Mar 9, 2026, 4:25 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $533.81 million as of March 9, 2026. Its market cap has increased by 990.21% in one year.
Market Cap
533.81M
Enterprise Value
502.63M
1-Year Change
990.21%
Ranking
Category
Stock Price
$10.13
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $533.81M, an increase of 711.95%. That is a compound annual growth rate of 64.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 489.54M | 77.63% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 513.21M |
| Forte Biosciences | 512.83M |
| CorMedix | 510.67M |
| ADC Therapeutics | 509.13M |
| Invivyd | 507.58M |
| Zevra Therapeutics | 505.55M |
| Lexeo Therapeutics | 499.96M |
| Eupraxia Pharmaceuticals | 481.69M |